SARTORIUS AG (1SRT.MI) Stock Fundamental Analysis

BIT:1SRT • DE0007165607

205 EUR
+205 (+Infinity%)
Last: Jan 8, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, 1SRT scores 3 out of 10 in our fundamental rating. 1SRT was compared to 18 industry peers in the Life Sciences Tools & Services industry. 1SRT has a bad profitability rating. Also its financial health evaluation is rather negative. 1SRT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year 1SRT was profitable.
  • 1SRT had a positive operating cash flow in the past year.
  • 1SRT had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 1SRT had a positive operating cash flow.
1SRT.MI Yearly Net Income VS EBIT VS OCF VS FCF1SRT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • With a Return On Assets value of 1.39%, 1SRT is not doing good in the industry: 77.27% of the companies in the same industry are doing better.
  • The Return On Equity of 1SRT (5.01%) is worse than 68.18% of its industry peers.
  • 1SRT's Return On Invested Capital of 4.71% is on the low side compared to the rest of the industry. 1SRT is outperformed by 72.73% of its industry peers.
  • 1SRT had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 9.64%.
Industry RankSector Rank
ROA 1.39%
ROE 5.01%
ROIC 4.71%
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1SRT.MI Yearly ROA, ROE, ROIC1SRT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • 1SRT's Profit Margin of 3.80% is on the low side compared to the rest of the industry. 1SRT is outperformed by 77.27% of its industry peers.
  • In the last couple of years the Profit Margin of 1SRT has declined.
  • 1SRT's Operating Margin of 14.06% is on the low side compared to the rest of the industry. 1SRT is outperformed by 68.18% of its industry peers.
  • 1SRT's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 46.48%, 1SRT is doing good in the industry, outperforming 68.18% of the companies in the same industry.
  • 1SRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.06%
PM (TTM) 3.8%
GM 46.48%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
1SRT.MI Yearly Profit, Operating, Gross Margins1SRT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • 1SRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 1SRT has more shares outstanding
  • Compared to 5 years ago, 1SRT has more shares outstanding
  • The debt/assets ratio for 1SRT has been reduced compared to a year ago.
1SRT.MI Yearly Shares Outstanding1SRT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
1SRT.MI Yearly Total Debt VS Total Assets1SRT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • 1SRT has an Altman-Z score of 2.19. This is not the best score and indicates that 1SRT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1SRT (2.19) is worse than 63.64% of its industry peers.
  • The Debt to FCF ratio of 1SRT is 8.92, which is on the high side as it means it would take 1SRT, 8.92 years of fcf income to pay off all of its debts.
  • 1SRT has a Debt to FCF ratio of 8.92. This is in the lower half of the industry: 1SRT underperforms 68.18% of its industry peers.
  • A Debt/Equity ratio of 1.28 is on the high side and indicates that 1SRT has dependencies on debt financing.
  • 1SRT has a Debt to Equity ratio of 1.28. This is in the lower half of the industry: 1SRT underperforms 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 8.92
Altman-Z 2.19
ROIC/WACC0.56
WACC8.36%
1SRT.MI Yearly LT Debt VS Equity VS FCF1SRT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 0.95 indicates that 1SRT may have some problems paying its short term obligations.
  • 1SRT has a worse Current ratio (0.95) than 81.82% of its industry peers.
  • 1SRT has a Quick Ratio of 0.95. This is a bad value and indicates that 1SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1SRT has a worse Quick ratio (0.49) than 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.49
1SRT.MI Yearly Current Assets VS Current Liabilites1SRT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • 1SRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
  • Measured over the past years, 1SRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.87% on average per year.
  • Looking at the last year, 1SRT shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
  • Measured over the past years, 1SRT shows a quite strong growth in Revenue. The Revenue has been growing by 13.10% on average per year.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%

3.2 Future

  • Based on estimates for the next years, 1SRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.87% on average per year.
  • Based on estimates for the next years, 1SRT will show a quite strong growth in Revenue. The Revenue will grow by 8.45% on average per year.
EPS Next Y22.67%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
EPS Next 5Y18.87%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.45%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SRT.MI Yearly Revenue VS Estimates1SRT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
1SRT.MI Yearly EPS VS Estimates1SRT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 44.96 indicates a quite expensive valuation of 1SRT.
  • Based on the Price/Earnings ratio, 1SRT is valued a bit more expensive than 72.73% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of 1SRT to the average of the S&P500 Index (27.13), we can say 1SRT is valued expensively.
  • Based on the Price/Forward Earnings ratio of 33.92, the valuation of 1SRT can be described as expensive.
  • 1SRT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1SRT is more expensive than 72.73% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1SRT to the average of the S&P500 Index (28.11), we can say 1SRT is valued slightly more expensively.
Industry RankSector Rank
PE 44.96
Fwd PE 33.92
1SRT.MI Price Earnings VS Forward Price Earnings1SRT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SRT is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, 1SRT is valued a bit cheaper than 68.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.07
EV/EBITDA 20.75
1SRT.MI Per share data1SRT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1SRT's earnings are expected to grow with 22.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.98
PEG (5Y)N/A
EPS Next 2Y21.45%
EPS Next 3Y22.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • 1SRT has a yearly dividend return of 0.37%, which is pretty low.
  • 1SRT's Dividend Yield is comparable with the industry average which is at 0.44.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1SRT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.37%

5.2 History

  • The dividend of 1SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 37.92% of the earnings are spent on dividend by 1SRT. This is a low number and sustainable payout ratio.
  • The dividend of 1SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.92%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
1SRT.MI Yearly Income VS Free CF VS Dividend1SRT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1SRT.MI Dividend Payout.1SRT.MI Dividend Payout, showing the Payout Ratio.1SRT.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SARTORIUS AG

BIT:1SRT (1/8/2026, 7:00:00 PM)

205

+205 (+Infinity%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-16
Earnings (Next)02-03
Inst Owners4.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.35B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target302.69 (47.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.37%
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.47%
PT rev (3m)2.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.14%
EPS NY rev (3m)-8.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.73%
Revenue NY rev (3m)-4.73%
Valuation
Industry RankSector Rank
PE 44.96
Fwd PE 33.92
P/S 4.36
P/FCF 32.07
P/OCF 17.56
P/B 5.75
P/tB N/A
EV/EBITDA 20.75
EPS(TTM)4.56
EY2.22%
EPS(NY)6.04
Fwd EY2.95%
FCF(TTM)6.39
FCFY3.12%
OCF(TTM)11.68
OCFY5.7%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)1.98
PEG (5Y)N/A
Graham Number60.46
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 5.01%
ROCE 6.33%
ROIC 4.71%
ROICexc 4.98%
ROICexgc 17.77%
OM 14.06%
PM (TTM) 3.8%
GM 46.48%
FCFM 13.61%
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 8.92
Debt/EBITDA 3.69
Cap/Depr 92.32%
Cap/Sales 11.25%
Interest Coverage 2.65
Cash Conversion 94.72%
Profit Quality 357.97%
Current Ratio 0.95
Quick Ratio 0.49
Altman-Z 2.19
F-Score7
WACC8.36%
ROIC/WACC0.56
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.67%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
EPS Next 5Y18.87%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.45%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.42%
EBIT Next 3Y38.38%
EBIT Next 5Y26.17%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%

SARTORIUS AG / 1SRT.MI FAQ

What is the ChartMill fundamental rating of SARTORIUS AG (1SRT.MI) stock?

ChartMill assigns a fundamental rating of 1 / 10 to 1SRT.MI.


What is the valuation status for 1SRT stock?

ChartMill assigns a valuation rating of 0 / 10 to SARTORIUS AG (1SRT.MI). This can be considered as Overvalued.


How profitable is SARTORIUS AG (1SRT.MI) stock?

SARTORIUS AG (1SRT.MI) has a profitability rating of 2 / 10.


How financially healthy is SARTORIUS AG?

The financial health rating of SARTORIUS AG (1SRT.MI) is 0 / 10.


Can you provide the expected EPS growth for 1SRT stock?

The Earnings per Share (EPS) of SARTORIUS AG (1SRT.MI) is expected to grow by 22.67% in the next year.